Women worrying about cancer
google_ad_client = “pub-3567370843393995″;
google_ad_width = 250;
google_ad_height = 250;
google_ad_format = “250×250_as”;
google_ad_type = “text”;
//2007-11-11: medicine-newlink
google_ad_channel = “7358653221″;
google_color_border = “FFFFFF”;
google_color_bg = “FFFFFF”;
google_color_link = “0000FF”;
google_color_text = “000000″;
google_color_url = “000000″;
//–>
A significant number of women worrying about cancer may be experiencing sleep disturbances, even without a breast cancer diagnosis, as per a research abstract that will be presented by Amita Dharawat, MD, on Monday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Posted in Uncategorized | No Comments »
Cost of cancer care on rise
google_ad_client = “pub-3567370843393995″;
google_ad_width = 250;
google_ad_height = 250;
google_ad_format = “250×250_as”;
google_ad_type = “text”;
//2007-11-11: medicine-newlink
google_ad_channel = “7358653221″;
google_color_border = “FFFFFF”;
google_color_bg = “FFFFFF”;
google_color_link = “0000FF”;
google_color_text = “000000″;
google_color_url = “000000″;
//–>
The cost of cancer care incurred during the period two months previous to cancer diagnosis and 12 months following diagnosis increased substantially between 1991 and 2002 for elderly patients in the United States, as per a research studypublished online June 10 in the Journal of the National Cancer Institute.
Posted in Uncategorized | No Comments »
Raloxifene reduces risk of invasive estrogen-receptor positive breast cancer
A prior analysis of data from the Raloxifene Use for the Heart (RUTH) trial, which enrolled women with coronary heart disease or those at an increased risk for the disease, showed that the drug did not protect against heart disease, which was one of the primary aims of the trial. But after a median follow up of 5.6 years, it did reduce the risk of invasive breast cancer by 44 percent, compared with women not taking the drug.
Posted in Uncategorized | No Comments »
Inherited melanoma risk: What you do know?
Salt Lake CityWhen people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactivelymuch like those who have already been diagnosed with the potentially deadly disease, as per results of a study completed at the University of Utah’s Huntsman Cancer Institute. and reported in the recent issue of Cancer Epidemiology, Biomarkers & Prevention
Tests for mutations in the CDKN2A gene can reveal a reason that melanomas “run” in families.
Posted in Uncategorized | No Comments »
Understanding Of Cell Behaviour In Breast Cancer
google_ad_client = “pub-3567370843393995″;
google_ad_width = 250;
google_ad_height = 250;
google_ad_format = “250×250_as”;
google_ad_type = “text”;
//2007-11-11: medicine-newlink
google_ad_channel = “7358653221″;
google_color_border = “FFFFFF”;
google_color_bg = “FFFFFF”;
google_color_link = “0000FF”;
google_color_text = “000000″;
google_color_url = “000000″;
//–>
The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Eventhough patients with early stage, small, breast tumours have an excellent short term prognosis, more than 15 to 20 per cent of them will eventually develop distant metastases, and die from the disease.
Posted in Uncategorized | No Comments »
Second Phase 1 Oncology Trial Further Demonstrates Interleukin-7 Potential To Induce Dramatic And Prolonged CD4 And CD8 T Cell Expansion
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of data from a phase 1 dose escalation study evaluating the effects of IL-7 therapy on human lymphocytes in subjects with non-hematologic, non-lymphoid cancer refractory to standard therapy.
Posted in Uncategorized | No Comments »
Prostate Cancer: NICE Clarification Boosts NHS Treatment Options
Physician experts at the British Association of Urological Surgeons’ (BAUS) annual meeting this week heard how discussions with NICE have opened the way for patients with prostate cancer to have continued access to cryotherapy - a promising therapy threatened by earlier NICE guidance published in February.
Posted in Uncategorized | No Comments »
Phase 1 Study Of Multi-Dose Administration Of Intravesical CG0070 In Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
ORLANDO, FL (UroToday.com) - CG0070 is a replication-competent adenovirus modified to replicate preferentially in retinoblastoma pathway-defective cancers and to express granulocyte-macrophage colony-stimulating factor (GM-CSF).
Posted in Uncategorized | No Comments »
Taming, Then Aiming, Viruses At Brain Tumors - “Engineered” Viruses May Hold Promise For Cancer Treatment
It may sound like the plot of a medical drama, but this approach to fighting cancer is real. Scientists say they may someday be able to battle brain cancer, while using a virus to do it. Early results from the lab are promising.
Posted in Uncategorized | No Comments »
Recipients Of 2008 Awards, Grants Announced By ASTRO
The American Society for Therapeutic Radiology and Oncology’s Research Evaluation Committee has announced the recipients of several awards and grants that are funded by the Radiation Oncology Institute (formerly the ASTRO Education and Development Fund) and distributed each year as part of the organization’s overall effort to prevent, treat and cure malignancies.
Posted in Uncategorized | No Comments »